Immune Pharma (IMNP) Misses Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts IMNP Hot Sheet
Join SI Premium – FREE
Immune Pharma (NASDAQ: IMNP) reported Q4 EPS of ($0.27), $0.13 worse than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Immune Pharma (IMNP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
